ADMP - Adamis Pharmaceuticals Corporation

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5126.97M
Enterprise Value 3121.54M
Trailing P/E N/A
Forward P/E 1-11.57
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)11.15
Price/Book (mrq)3.31
Enterprise Value/Revenue 310.67
Enterprise Value/EBITDA 6-6.41

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Jun 30, 2017
Profit Margin -158.56%
Operating Margin (ttm)-194.00%
Management Effectiveness
Return on Assets (ttm)-37.69%
Return on Equity (ttm)-73.95%
Income Statement
Revenue (ttm)11.39M
Revenue Per Share (ttm)0.51
Quarterly Revenue Growth (yoy)97.40%
Gross Profit (ttm)1.62M
EBITDA -18.97M
Net Income Avi to Common (ttm)-19.43M
Diluted EPS (ttm)-0.87
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)10.74M
Total Cash Per Share (mrq)0.34
Total Debt (mrq)5.3M
Total Debt/Equity (mrq)15.68
Current Ratio (mrq)2.19
Book Value Per Share (mrq)1.22
Cash Flow Statement
Operating Cash Flow (ttm)-17.01M
Levered Free Cash Flow (ttm)-10.06M

Trading Information

Stock Price History
Beta 0.79
52-Week Change 337.29%
S&P500 52-Week Change 317.43%
52 Week High 36.45
52 Week Low 32.55
50-Day Moving Average 34.95
200-Day Moving Average 34.84
Share Statistics
Avg Vol (3 month) 3594.91k
Avg Vol (10 day) 3827.38k
Shares Outstanding 531.35M
Float 26.65M
% Held by Insiders 19.26%
% Held by Institutions 116.72%
Shares Short 33.38M
Short Ratio 35.87
Short % of Float 315.94%
Shares Short (prior month) 35.34M
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/17
Last Split Date 3Dec 13, 2013